Hexarelin peptide
Hexarelin is a synthetic peptide belonging to a class of compounds known as growth hormone secretagogues (GHS). These peptides stimulate the release of growth hormone through pathways related to the hormone ghrelin.
Hexarelin peptide was developed during pharmaceutical research exploring compounds capable of influencing growth hormone secretion and endocrine regulation.
Because of its biological activity, hexarelin has been studied in experimental research related to metabolism, endocrine signaling, and cardiovascular physiology.
How Hexarelin peptide works
Hexarelin peptide acts primarily by activating the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. Activation of this receptor may:
stimulate growth hormone release from the pituitary gland
increase circulating IGF-1 levels through the GH axis
influence metabolic pathways related to energy regulation
Some experimental studies have also investigated possible interactions with cardiovascular and protective cellular pathways, although these mechanisms remain under investigation.
Clinical trials and evidence
Research involving hexarelin has included laboratory studies and early clinical investigations examining its effects on growth hormone secretion and endocrine regulation. Studies have explored:
stimulation of GH secretion in humans
experimental treatment approaches for growth hormone deficiency
cardiovascular research related to cardiac protection mechanisms
Despite these investigations, hexarelin has not progressed to widespread pharmaceutical approval, and most available information comes from experimental and early clinical research.
Possible side effects of Hexarelin peptide:
Because hexarelin influences hormonal signaling pathways, potential side effects may include:
increased appetite
flushing
headache
fatigue
injection site reactions
As with other investigational peptides affecting endocrine pathways, the long-term safety profile has not been fully established.